Skip to main content
Premium Trial:

Request an Annual Quote

Population Genetics Technologies Gains $7.5M in Venture Capital

This article has been corrected to reflect the appropriate conversion rate to US dollars.
 
NEW YORK (GenomeWeb News) – Population Genetics Technologies has raised £3.8 million (approximately $7.5 million) in a first round of funding, the company said Wednesday.
 
The Series A round included investments from Auriga Partners, Noble Fund Managers, and Compass Genetics Investors.
 
Cambridge, UK-based PGT was started with seed funding from the Wellcome Trust Technology Transfer Division to develop and market new technologies for population studies.
 
Sam Eletr, one of PGT's co-founders, said that the company's large-scale population genetics method “if successful, will be a huge leap forward, as it is expected to reduce significantly the cost of using any sequencing technology, however efficient, that can analyze only one genome at a time.”
 
The firm said its technology could “enable users to discover shared gene variants characteristic of a particular disorder or a specific response to drugs without the need to sequence separately every individual genome in a particular population.”
 
PGT also announced that it has appointed Mel Kronick as CEO and a member of the board of directors. Kronick is a former division R&D manager for both Agilent Technologies and Applied Biosystems, with broad experience in the DNA sequencing and microarray fields.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.